CA2 and tuberous sclerosis: The observation that genetic manipulations reduce the number of intercalated cells, for example, the ablation of the Car2 gene, suggests a new approach that can complement the current mTORC1 inhibition approach that is used for the treatment of TSC renal cystic disease.